| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 253.47M | 225.72M | 250.42M | 202.84M | 172.58M |
| Gross Profit | 149.91M | 139.12M | 51.77M | 59.66M | 24.08M |
| EBITDA | 24.41M | -11.88M | 50.58M | 36.06M | 41.49M |
| Net Income | -17.20M | -18.61M | 3.97M | -4.89M | 3.81M |
Balance Sheet | |||||
| Total Assets | 91.56M | 134.05M | 133.39M | 116.52M | 129.82M |
| Cash, Cash Equivalents and Short-Term Investments | 17.53M | 29.10M | 46.93M | 28.82M | 48.44M |
| Total Debt | 52.68M | 79.02M | 61.23M | 60.53M | 63.75M |
| Total Liabilities | 80.66M | 105.95M | 86.68M | 73.77M | 82.18M |
| Stockholders Equity | 10.90M | 28.10M | 46.71M | 42.74M | 47.64M |
Cash Flow | |||||
| Free Cash Flow | 30.64M | 24.25M | 57.87M | 20.34M | 31.23M |
| Operating Cash Flow | 32.46M | 30.35M | 62.69M | 26.91M | 33.88M |
| Investing Cash Flow | -3.16M | -6.06M | -4.82M | -6.56M | -2.64M |
| Financing Cash Flow | -40.88M | -40.06M | -41.82M | -37.92M | -33.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | HK$71.00M | 2.72 | -3.70% | ― | 6.55% | 98.02% | |
49 Neutral | HK$36.05M | 1.09 | -48.61% | ― | 1.39% | -206.25% | |
46 Neutral | HK$37.27M | -14.28 | ― | ― | 144.78% | 10.07% | |
44 Neutral | HK$33.55M | -0.43 | -120.93% | ― | 2.67% | -264.58% | |
41 Neutral | HK$10.16M | -0.55 | ― | ― | -77.80% | -586.04% | |
40 Underperform | HK$24.25M | -4.11 | -27.31% | ― | 14.18% | 42.51% |